본문 바로가기
KERD
논문KCI 등재

The Effects of Repetitive Transcranial Magnetic Stimulation at Dorsolateral Prefrontal Cortex in the Treatment of Migraine Comorbid with Depression: A Retrospective Open Study

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Objective: The literature on managing migraine non-responsive to pharmacological approaches and that co-occurring with depression is scanty. The comorbid condition predicts a poorer prognosis for migraine as well as depression. The present report assesses efficacy and tolerability of high frequency repetitive transcranial magnetic stimulation (rTMS) over left dorsolateral prefrontal cortex as a treatment modality for migraine with comorbid depression. Methods: The current retrospective chart review assesses effectiveness of high frequency rTMS over left dorsolateral prefrontal cortex as a treatment modality to manage migraine occurring comorbid with depression in 14 subjects. Results: The mean scores on Migraine Disability Assessment Test (MIDAS) and depression rating scale reduced significantly from 21.14±3.01 and 20.71±3.95 at baseline to 13.93±6.09 and 14.21±5.52 respectively, after rTMS. There was significant improvement in migraine frequency, severity and functional disability assessed using MIDAS scores (p <0.05) following high frequency rTMS compared to baseline. Conclusion: There is a role of applying rTMS as a potential therapeutic modality in the integrated management of a distinct subgroup of migraine patients with comorbid depression.

Abstract

Objective: The literature on managing migraine non-responsive to pharmacological approaches and that co-occurring with depression is scanty. The comorbid condition predicts a poorer prognosis for migraine as well as depression. The present report assesses efficacy and tolerability of high frequency repetitive transcranial magnetic stimulation (rTMS) over left dorsolateral prefrontal cortex as a treatment modality for migraine with comorbid depression. Methods: The current retrospective chart review assesses effectiveness of high frequency rTMS over left dorsolateral prefrontal cortex as a treatment modality to manage migraine occurring comorbid with depression in 14 subjects. Results: The mean scores on Migraine Disability Assessment Test (MIDAS) and depression rating scale reduced significantly from 21.14±3.01 and 20.71±3.95 at baseline to 13.93±6.09 and 14.21±5.52 respectively, after rTMS. There was significant improvement in migraine frequency, severity and functional disability assessed using MIDAS scores (p <0.05) following high frequency rTMS compared to baseline. Conclusion: There is a role of applying rTMS as a potential therapeutic modality in the integrated management of a distinct subgroup of migraine patients with comorbid depression.

참고문헌 (24)

  1. Global Burden of Disease Study 2013 Collaborators, "Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013", Lancet, 386, pp.743~800 (2015)[DOI]
  2. Hamelsky SW, "Psychiatric comorbidity of migraine", Headache, 46, pp.1327~1333 (2006)[DOI]
  3. Lampl C, "Headache, depression and anxiety: associations in the Eurolight project", J Headache Pain, 17, pp.59~ (2016)[DOI]
  4. Lanteri-Minet M, "Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management", Pain, 118, pp.319~326 (2005)[DOI]
  5. Breslau N, "Comorbidity of migraine and depression: investigating potential etiology and prognosis", Neurology, 60, pp.1308~1312 (2003)[DOI]
  6. Baskin SM, "Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications", Neurol Sci, 30(Suppl 1), pp.S61~S65 (2009)[DOI]
  7. André Aleman, "Use of Repetitive Transcranial Magnetic Stimulation for Treatment in Psychiatry", Clinical Psychopharmacology and Neuroscience, 11(2), pp.53~59 (2013), 대한정신약물학회
  8. Li CT, "Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism", J Affect Disord, 127, pp.219~229 (2010)[DOI]
  9. Mongini F, "Frontal lobe dysfunction in patients with chronic migraine: a clinical-neuropsychological study", Psychiatry Res, 133, pp.101~106 (2005)[DOI]
  10. Brighina F, "Abnormal facilitatory mechanisms in motor cortex of migraine with aura", Eur J Pain, 15, pp.928~935 (2011)[DOI]
  11. Headache Classification Subcommittee of the International Headache Society, "The International Classification of Headache Disorders: 2nd edition", Cephalalgia, 24(Suppl 1), pp.9~160 (2004)[DOI]
  12. Hamilton M, "A rating scale for depression", J Neurol Neurosurg Psychiatry, 23, pp.56~62 (1960)[DOI]
  13. Rossi S, "Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research", Clin Neurophysiol, 120, pp.2008~2039 (2009)[DOI]
  14. Pascual-Leone A, "Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression", Lancet, 348, pp.233~237 (1996)[DOI]
  15. Stewart WF, "An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score", Neurology, 53, pp.988~994 (1999)[DOI]
  16. Brighina F, "rTMS of the prefrontal cortex in the treatment of chronic migraine: a pilot study", J Neurol Sci, 227, pp.67~71 (2004)[DOI]
  17. Lorenz J, "Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation", Brain, 126, pp.1079~1091 (2003)[DOI]
  18. Rome JD, "Limbically augmented pain syndromes: kindling andcorticolimbic sensitisation", Cephalalgia, 21, pp.241~245 (2001)[DOI]
  19. Misra UK, "Is <TEX>${\beta}$<", TEX> endorphin related to migraine headache and its relief?, 2013, pp.33, 316~322
  20. Conforto AB, "Randomized, proof-of-principle clinical trial of active transcranial magnetic stimulation in chronic migraine", Cephalalgia, 34, pp.464~472 (2014)[DOI]
  21. Gudmundsson LS, "Migraine, depression, and brain volume: the AGES-Reykjavik Study", Neurology, 80, pp.2138~2144 (2013)[DOI]
  22. Maizels M, "A review of screening tools for psychiatric comorbidity in headache patients", Headache, 46(Suppl 3), pp.S98~S109 (2006)[DOI]
  23. Perera T, "The Clinical TMS Society consensus review and treatment recommendations for TMS therapy for major depressive disorder", Brain Stimul, 9, pp.336~346 (2016)[DOI]
  24. Macedo A, "Placebo response in the prophylaxis of migraine: a meta-analysis", Eur J Pain, 12, pp.68~75 (2008)[DOI]

관련 논문AI추천

Repetitive Transcranial Magnetic Stimulation to Treat Depression and Insomnia with Chronic Low Back Pain박은정, 이세진, 한윤민, Do Yle Koh대한통증학회 · The Korean Journal of Pain2014 · 제27권 제3호Predictors of Response to Repetitive Transcranial Magnetic Stimulation in Depression: A Review of Recent UpdatesSujita Kumar Kar대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2019 · 제17권 제1호Repetitive transcranial magnetic stimulation for neuropathic pain김수영, 손은희, 이은경대한임상신경생리학회 · Annals of Clinical Neurophysiology2022 · 제24권 제2호The Efficacy of Miniaturized Repetitive Transcranial Magnetic Stimulation in Patients with DepressionJeong-Ho Chae, Kuk-In Jang, Sangmin Lee, Sejin Yoon대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2019 · 제17권 제3호Personalization of Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depressive Disorder According to the Existing Psychiatric ComorbidityAlexander T. Sack, Che-Sheng Chu, Hsin-An Chang, Kuan-Pin Su, Ming-Kuei Lu, Po-Han Chou, Taishiro Kishimoto, Wei Hung Chang, Yen-Feng Lin대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2021 · 제19권 제2호Treatment-Resistant Depression Entering Remission Following a Seizure during the Course of Repetitive Transcranial Magnetic Stimulation강희주, Il-Seon Shin, Jae-Min Kim, Jin Sang Yoon, Ju Wan Kim, Kyung-Yeol Bae, Sung-Wan Kim대한신경정신의학회 · PSYCHIATRY INVESTIGATION2016 · 제13권 제4호

이 간행물의 다른 논문 (15건)